Li Yirong, Wu Jianming, Wang Lin, Chen Fenghua, Hu Lihua
Department of Laboratory & Institute of Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Techonology, Wuhan 430022.
J Huazhong Univ Sci Technolog Med Sci. 2004;24(1):48-51. doi: 10.1007/BF02830704.
Telomerase activity and the expression of telomerase subunits (for example, telomerase reverse transcriptase and telomerase associated protein 1 and telomerase RNA component) of peripheral white blood cells were detected in the patients with acute myelogenous leukaemia (AML) and the correlation between telomerase activity and the expression of telomerase subunits was observed. In 94 peripheral white blood cells from 18 healthy volunteers and 76 patients with AML, including 31 AML at initial presentation, 24 at relapse and 21 at complete remission, the telomerase activity and telomerase subunits mRNA or RNA were detected by PCR-ELISA and RT-PCR respectively. The results showed that the positive rate of telomerase from patients with AML at initial presentation, at relapse and at complete remission was 74.1%, 79.2% and 4.8% respectively. The positive rate of telomerase reverse transcriptase mRNA from healthy volunteers, AML at initial presentation, AML at relapse and AML at complete remission was 5.6%, 80.6%, 83.3% and 9.5% respectively. The positive rate of telomerase associated protein 1 mRNA and telomerase RNA component in all samples were 100%. It was suggested that the up-regulation of telomerase activity and the expression of telomerase reverse transcriptase is correlated closely with the occurrence and relapse of AML, so telomerase activity and the expression of telomerase reverse transcriptase may be used to estimate the curative effect and predict relapse of AML. Moreover, the up-regulation of telomerase activity is correlated with the expression of telomerase reverse transcriptase significantly.
检测急性髓系白血病(AML)患者外周血白细胞的端粒酶活性及端粒酶亚基(如端粒酶逆转录酶、端粒酶相关蛋白1和端粒酶RNA组分)的表达,并观察端粒酶活性与端粒酶亚基表达之间的相关性。在来自18名健康志愿者的94份外周血白细胞及76例AML患者(包括31例初诊AML、24例复发AML和21例完全缓解AML)中,分别采用PCR-ELISA和RT-PCR检测端粒酶活性及端粒酶亚基mRNA或RNA。结果显示,初诊AML、复发AML和完全缓解AML患者的端粒酶阳性率分别为74.1%、79.2%和4.8%。健康志愿者、初诊AML、复发AML和完全缓解AML患者的端粒酶逆转录酶mRNA阳性率分别为5.6%、80.6%、83.3%和9.5%。所有样本中端粒酶相关蛋白1 mRNA和端粒酶RNA组分的阳性率均为100%。提示端粒酶活性及端粒酶逆转录酶表达上调与AML的发生及复发密切相关,端粒酶活性及端粒酶逆转录酶表达可用于评估AML的疗效及预测复发。此外,端粒酶活性上调与端粒酶逆转录酶表达显著相关。